MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension

Bimatoprost
DOI: 10.1007/s00417-023-06192-0 Publication Date: 2023-08-24T09:02:43Z
ABSTRACT
PURPOSE : To compare the efficacy and safety of fixed-dose combination (FDC) netarsudil 0.02%/latanoprost 0.005% ophthalmic solution (NET/LAT; Roclanda
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (34)
CITATIONS (12)